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Abstract: Mice and human patients with impaired vitamin D receptor (VDR) signaling have 
normal developmental hair growth but display aberrant post-morphogenic hair cycle progression 
associated with alopecia. In addition, VDR–/– mice exhibit impaired cutaneous wound healing. We 
undertook experiments to determine whether the stress-inducible regulator of energy homeostasis, 
DNA damage-inducible transcript 4 (Ddit4, is involved in these processes. By analyzing hair cycle 
activation in vivo, we show that VDR-/- mice at day 14 exhibit increased Ddit4 expression within 
follicular stress compartments. At day 29, degenerating VDR-/- follicular keratinocytes, but not 
bulge stem cells, continue to exhibit an increase in Ddit4 expression. At day 47, when normal 
follicles and epidermis are quiescent and enriched for Ddit4, VDR-/- skin lacks Ddit4 expression. In 
a skin wound healing assay, the re-epithelialized epidermis in wildtype (WT) but not VDR-/- 
animals harbor a population of Ddit4- and Krt10-positive cells. Our study suggests that VDR 
regulates Ddit4 expression during epidermal homeostasis and the wound healing process, while 
elevated Ddit4 represents an early growth-arresting stress response within VDR-/- follicles. 
Keywords: wound repair; VDR; mTOR; DDIT4; stress; hair follicle; stem cells 
 
1. Introduction 
Besides its known regulation of mineral homeostasis, the vitamin D receptor (VDR) also plays a 
functional role within the cutaneous environment. The importance of the cutaneous VDR is 
demonstrated in certain human patients with hereditary vitamin D-resistant rickets and mice that 
harbor loss-of-function mutations in the VDR and eventually develop hair loss (alopecia totalis [1]), 
as well as impaired skin wound repair [2,3]. In utero, the epithelium and underlying mesenchyme 
interact to form hair follicles during morphogenesis, which ends during the second week of life in 
mice. During the ensuing post-morphogenic hair cycle, the permanent follicular component is 
retained, which includes sebaceous glands and the upper outer root sheath that harbors the hair 
follicle stem cell center called the bulge. In contrast, the lower part of the follicle cycles through 
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episodic periods of growth, regression and quiescence, termed the anagen, catagen and telogen 
stages respectively. The telogen-to-anagen transition marks a stage in which stem cells become 
activated to form a new hair bulb with concomitant inner root sheath (IRS) and hair shaft 
differentiation. 
The VDR is thought to play a limited role during the early morphogenic period of follicular 
development since VDR-/- mice appear grossly normal and generate their first coat of hair [4]. 
However, VDR-/- mice exhibit compromised post-morphogenic hair cycles and improper anagen 
initiation and integrity, in which mutant mice do not grow new hair, and instead the follicles become 
epidermal cysts [5–7]. The signaling defects within VDR-deficient hair follicles are localized to 
keratinocytes, and not to the mesenchymal component of the follicle [6–8]. Through a series of 
recovery transgenesis experiments in mice, studies have shown that the zinc finger DNA binding 
domain of the VDR, but not the ligand binding or activation function 2domains, was critical for the 
hair cycle [9–11]. 
Despite these studies, the biological explanation for hair loss in VDR-deficient mice remains 
unclear. The VDR was identified as a major molecular signature within hair bulge label-retaining 
stem cells [12], with subsequent studies suggesting that unliganded VDRs are required for the 
self-renewal, colony formation and normal lineage specification, as well as function of bulge 
keratinocyte stem cells (KSCs; [13]). However other follow-up studies observed no functional defects 
in VDR-deficient KSCs [14]. Hair follicle induction and maintenance are controlled by numerous 
factors such as fibroblast growth factor , transforming growth factor beta , Hedgehog and Wnt 
signaling, by controlling the self-renewal and lineage progression of KSCs and activation of 
progenitor cells. Studies suggest that VDR interactions with the lymphoid enhancer-binding factor 1 
(lef1) transactivator may be the mechanism by which the unliganded VDR promotes Wnt signaling 
[13,15]. Importantly, it was shown that the VDR interaction with the canonical Wnt target gene, 
Axin2, was perturbed in both VDR-null and Lef1-null keratinocytes [16]. Furthermore, the 
Hedgehog signaling pathway was found to be disrupted in VDR- and Lef1-null keratinocytes, thus 
contributing to defective follicular signaling [16,17]. 
Besides its role in hair follicle biology, the VDR is expressed ubiquitously in the basal layer of 
the interfollicular epidermis [14], and plays a role in epidermal integrity and wound repair. In the 
epidermis, the biologically active form of vitamin D, 1,25-dihydroxyvitamin D (1,25D3), is known to 
suppress tumor formation, promote innate antimicrobial immunity, suppress epidermal 
keratinocyte proliferation and promote differentiation and formation of the permeability barrier 
(reviewed in [18]). Epidermal abnormalities are observed in VDR-/- mice at as early as one week of 
age, with age-dependent reduction of differentiation markers and lipid content [4,19,20]. 
Consequently, the epidermis of VDR-/- mice is generally thicker and more folded, reflecting 
enhanced epidermal proliferation [21]. In contrast to VDR-/- mice, mice lacking the enzyme that 
catalyzes synthesis of 1,25D3 (cytochrome p450 27B1; CYP27B1-/-) have normal hair, but altered 
epidermal differentiation signatures, impaired permeability barrier and wound healing responses, 
suggesting that 1,25D3 is crucial for epidermal integrity [22,23]. The cutaneous wound healing 
defects in global VDR-/- animals have been characterized by scarcity of infiltrating macrophages in 
the early inflammatory phase and disrupted vascular invasion of granulation tissue, yet 
re-epithelialization was reported to be unaffected [2]. In contrast, epithelial-specific deletion of the 
VDR in mice results in impaired re-epithelialization of wounds [3]. Also, in vitro scratch migration 
assays using VDR-/- primary keratinocytes showed decreased injury-stimulated migration [14]. 
Mechanistic/mammalian target of rapamycin (mTOR) is a serine-threonine protein kinase that 
is considered to be a “master regulator” of cell growth and survival. It is the major checkpoint for 
sensing of cellular nutrients and oxygen and energy levels to orchestrate the cellular responses to 
any changes. Upstream inhibitors of mTOR have been characterized, including DNA 
damage-inducible transcript 4 (Ddit4), also called REDD1, a mitochondrial protein which is involved 
in the conservation of energy resources. Ddit4 was first identified as a stress response gene 
transcriptionally activated upon UV-induced DNA damage [24], and then during hypoxia, oxidative 
stress, endoplasmic reticulum (ER) stress, atrophied glucocorticoid treatment and energy/serum 
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deprivation [25–28]. We have recently shown that Ddit4/DDIT4 is a direct and conserved 
transcriptional target of the VDR in human and mouse bone-forming osteoblasts to promote 
differentiation [29,30]. In view of the ubiquitous expression pattern of Ddit4 within the mammalian 
system, the present study focused on potential cutaneous interactions between VDR and Ddit4 
signaling. Accordingly we hypothesize that in mice: 1) Ddit4 is functionally regulated by the VDR 
during the hair cycle and epidermal wound repair, and 2) given its known role as a stress-inducible 
factor, Ddit4 may be utilized as an innate surveyor of VDR-dependent adverse cellular effects. By 
monitoring the effects on Ddit4 we were able to show that the VDR and Ddit4 function distinctly at 
the crossroads between hair follicle cycling and the epidermal wound repair process. 
2. Results 
2.1. DDIT4/Ddit4 Is an Acute Phase Effector of Stress Related to Inflammatory and Other Immune Challenges 
to Physical or Bacterial Complications 
We initially sought a general assessment under which biological stresses regulate DDIT4/Ddit4 
gene expression within keratinocytes and other epithelial cell types. To do this, we appraised the 
publically available Gene Expression Omnibus (GEO) Profiles repository of curated microarray/next 
generation sequencing datasets for individual gene expression profiles (available at: 
http://www.ncbi.nlm.nih.gov/geoprofiles). We identified five (cutaneous) experimental DataSet 
records whereby DDIT4/Ddit4 was significantly regulated compared to control samples. In a study 
to explore the space effects of heavy Fe ion radiation exposure of a rat keratinocyte line, Ddit4 
mRNA expression was decreased, despite the induction of other “DNA repair” genes within the 
data set [31] and original discovery of Ddit4 as a major transcript activated by UV irradiation [24] 
(Figure 1A). In contrast, under the stress of inflammation (i.e., via overexpression of the NF-κB 
activator IKKβ) [32] or specific types of periodontal pathogens [33], Ddit4/DDIT4 transcript was 
increased within mouse skin and human gingival epithelial cells, respectively (Figure 1B,C). In 
another study, human keratinocytes that were exposed to an enzymatic cell disassociation treatment 
as a model of epidermal injury [34], resulted in elevated DDIT4 message (Figure 1D). In a more 
unperturbed physiological setting, multipotent human hair follicle stem cells were co-cultured with 
mesenchymal dermal papilla cells to induce keratinocyte progenitor differentiation, whereby DDIT4 
message levels decreased over time [35]. 
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Figure 1. Gene Expression Omnibus (GEO) profile assessment of Ddit4/DDIT4 responses to 
biological and stress conditions within epithelial cells. (1.5 column) (A) For all DataSets presented in 
this figure, the graphs represent Ddit4/DDIT4 transcript levels. DataSet GDS2637 shows that Ddit4 
was not induced after 56FE ion irradiation within a rat keratinocyte cell line; (B) DataSet GDS3766 
shows that NF-κB activation by IKKβ overexpression in mouse dorsal skin resulted in increased 
Ddit4 levels; (C) DataSet GDS3211 reports that periodontal pathogen infection of a human gingival 
epithelial cell line with Aggregatibacter actinomycetemcomitans led to DDIT4 induction; (D) DataSet 
GDS4608 shows that upon injury of human epidermal cells, DDIT4 transcript levels were increased 
compared to uninjured samples; (E) DataSet GDS687 shows that differentiation of keratinocyte stem 
cells upon mesenchymal-epithelial interactions resulted in decreased DDIT4 expression over time. 
All DataSets can be accessed at: http://www.ncbi.nlm.nih.gov/geoprofiles. 
2.2. VDR Positively Regulates Ddit4 mRNA and Protein Expression in Primary Murine Epidermal 
Keratinocytes 
To investigate the VDR-Ddit4 relationship within the mouse cutaneous system, we first 
determined whether 1,25D3-VDR actions could transcriptionally activate Ddit4 within primary 
epidermal keratinocytes harvested and cultured from neonatal pups aged 2–3 days derived from 
either wildtype (WT) or VDR-/- mice on a normalized calcium/phosphorous diet. Since keratinocytes 
differentiate with calcium, our culture system was established using low-calcium conditions (0.05 
mM) to mimic undifferentiated cells in the basal layer that have the highest concentration and 
effectiveness of the VDR [36]. Treatment of WT, but not VDR-/- cells with 1,25D3 (1–100 nM) for 6 h 
resulted in a dose-dependent induction of both cyp24a1 (1,25-dihydroxyvitamin D3 24-hydroxylase), 
a major transcriptional target and negative feedback regulator of vitamin D, and Ddit4 (Figure 2A). 
Expression of Ddit4 mRNA levels in primary keratinocytes was significantly lower in VDR-/- mice, 
but transfection of these cells with a murine Vdr transgene resulted in re-expression of Ddit4, and 
enhanced induction after 1,25D3 treatment (Figure 2B). These results demonstrate that Ddit4 is 
directly controlled by VDR actions. 
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Figure 2. Regulation of the mechanistic/mammalian target of rapamycin (mTOR) inhibitor and stress 
sensor DNA damage-inducible transcript 4 (Ddit4) by liganded vitamin D receptors (VDRs) within 
primary keratinocytes (column 1.5). (A) Dose-dependent transcriptional induction of Cyp24a1 and 
Ddit4 by 1,25-dihydroxyvitamin D (1,25D3, 6 h) in wildtype (WT), but not VDR-/-, primary 
keratinocytes derived from neonatal pups; (B) Transient transfection of VDR-/- primary keratinocytes 
with a mVDR plasmid restores endogenous Ddit4 transcript levels. Combined treatment further 
enhanced Ddit4 mRNA levels (with mVDR transfection and 1,25D3 of 10 nM for 6 h); (C) 
Immunofluorescence detection of Ddit4 within primary keratinocytes. WT, but not VDR-/-, primary 
keratinocytes exposed to 10nM 1,25D3 for 18 h resulted in increased intracellular accumulation of 
Ddit4 (white arrows). Ddit4 upregulation in response to fetal bovine serum deprivation for 24 h in 
both WT and VDR-/- keratinocytes. One-way ANOVA at an α = 0.05 (95% confidence interval) and 
Tukey’s multiple comparison post-tests were utilized. Significance is denoted with asterisks: * p < 
0.05 (n = 3–4 experiments). RT-qPCR; reverse transcription quantitative polymerase chain reaction.  
Next we investigated the effects on Ddit4 protein expression within WT and VDR-/- primary 
keratinocytes using immunofluorescence staining. In WT cells treated with 1,25D3 (10 nM) for 18 h in 
growth medium supplemented with FBS with reduced-calcium (0.05 mM), we observed an 
increased number of cells with elevated intracellular accumulation of Ddit4 (Figure 2C, upper 
middle panel). In addition, these 1,25D3-treated WT keratinocytes appeared to be morphologically 
distinct (i.e., enlarged and differentiated) compared to their VDR-/- counterparts. The 1,25D3-treated 
VDR-null cells appear to acquire higher length:width ratios, indicative of an undifferentiated motile 
state (Figure 2C, lower middle panel). Likewise, after 1,25D3 treatment of VDR-null keratinocytes, 
there was a comparable decrease in Ddit4 expression to that of WT cells. As a safeguard for energy 
conservation, Ddit4 expression is known to be enhanced under stress conditions such as growth 
factor (serum) deprivation [25]. With this in mind, we tested this response in WT keratinocytes and 
observed increased Ddit4 protein expression after serum starvation (Figure 2C, upper right panel). 
Interestingly, Ddit4 expression was also enhanced in VDR-/- keratinocytes under serum-deprived 
conditions (Figure 2C, lower right panel). These results suggest that (1) the Ddit4-mediated energy 
and growth factor depletion sensing mechanism has the potential to function independent of cellular 
VDRs, and (2) endogenous Ddit4 activation can be used as an innate surveillant for catabolic stress 
within the VDR loss-of-function system. 
2.3. Ddit4 Is a Direct Transcriptional Effector of the Liganded VDR within Primary Epidermal Keratinocytes 
Transcriptional regulation by 1,25D3 involves occupancy of VDREs on effector genes by 
1,25D3-bound or unbound VDRs and numerous other co-regulators. Here, we performed chromatin 
immunoprecipitation (ChIP) qPCR assays to assess potential VDRs and general transcriptional 
element binding to the Ddit4 promoter within WT neonatal primary keratinocytes. We tiled the 
proximal promoter region (i.e., with primers Ddit4-1 and Ddit4-2), which was approximately 500 
base pairs upstream of the Ddit4 transcriptional start site (TSS) on the reverse strand. The distal 
region was appraised using primer Ddit4-3, which targeted a DNA region 1.7 kilobases upstream of 
the TSS. All sequence positions were based on the primary assembly GRCm38 released by the 
Genome Reference Consortium in 2012 based on the Mus musculus strain C57BL/6J. 
ChIP results show that endogenous VDRs bound strongly to the proximal promoter of Ddit4 
under unstimulated conditions (Figure 3AI). Upon 1,25D3 stimulation (10 nM, 15 min) there was 
increased recruitment of liganded VDRs to the proximal, but not distal, promoter region of Ddit4 as 
assessed by ChIP-qPCR (Figure 3B). These results suggest that the promoter region of Ddit4 in 
keratinocytes includes functional VDRE(s). Although the unliganded VDR bound to the proximal 
Ddit4 promoter, this represented a transcriptionally inactive state as RNA polymerase 2 (RNApol2), 
a general marker for precursor RNA synthesis, was tethered or poised at the more distal region 
(Figure 3A, bottom panel). In contrast, there was accompanying RNApol2 binding activity at the 
proximal Ddit4 promoter only after 1,25D3 treatment, suggesting direct transcriptional activation of 
Ddit4 after ligand stimulation (Figure 3C). For ChIP validation we utilized the murine osteocalcin 
gene, Bglap, which has no VDREs in its promoter region, nor is it transcriptionally influenced by 
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addition of 1,25D3 [37]. We also chose the S1 site within intron 3 and 4 of the murine Vdr gene as a 
potent positive control for both auto-regulatory VDR and RNApol2 binding, as previously shown in 
MC3T3-E1 murine osteoblasts [38]. Interestingly in primary keratinocytes, VDRs but not RNApol2, 
bound to the S1 site, suggesting cell type-specific usage of this transcriptional auto-regulatory site. 
All ChIP-qPCR results were normalized to a validated non-specific (NS) “naked” control target site . 
Overall, our findings support the notion that the liganded VDR directly targets the Ddit4 promoter 
to induce transcription within primary epidermal keratinocytes. 
 
Figure 3. Ddit4 transcriptional activity is directly regulated by the VDR within primary epidermal 
keratinocytes (1.5 column). (A) Representative chromatin immunoprecipitation (ChIP) gel images of 
VDR and RNA polymerase 2 (RNApol2) interactions at the Ddit4 promoter region within WT 
primary keratinocytes. Figure 3AI shows VDR immunoprecipitation, while Figure 3AII shows 
RNApol2 immunoprecipitation results. Cells were treated with 1,25D3 (10 nM) for 15 min, fixed and 
then the chromatin was purified. NS (non-specific), OC (osteocalcin), and VDR-S1 (VDR intron 3 and 
4) genomic sites were used for control purposes. P (proximal), D (distal), VDRE (putative vitamin D 
response element); (B) ChIP-Quantitative PCR (qPCR) analysis of VDR immunoprecipitation; (C) 
ChiP-qPCR analysis of RNApol2 immunoprecipitation. One-way ANOVA at an α = 0.05 (95% 
confidence interval) and Tukey’s multiple comparison post-tests were utilized. Significance is 
denoted with asterisks: ** p < 0.01 (n = 4 experiments) 
2.4. Formation of Ddit4-Positve Stress Compartments in VDR-/- Morphogenic Follicles and Reduced Ddit4 
Epidermal Expression 
Having shown a direct transcriptional relationship between the VDR and Ddit4 within primary 
keratinocytes, we next sought to decipher the potential in vivo role of Ddit4 during activation and 
resting stages of the hair follicle cycle and epidermal homeostasis. Hair follicle morphogenesis 
initiates during embryogenesis and ceases approximately 2–3 weeks postnatally, whereby the 
ensuing post-morphogenic hair cycle marks a new anagen stage (Figure 4A). Using 
immunostaining, we monitored Ddit4 protein expression during transitioning hair follicular and 
epidermal keratinocytes through morphogenic and post-morphogenic stages within WT and VDR-/- 
mice maintained on a rescue diet. Catagen is a transitional apoptosis-mediated involution stage that 
signals the end of the active growth of hair. Importantly, the VDR is selectively expressed in hair 
follicle keratinocytes during late anagen and catagen stages, which reflects the reduced period of 
proliferation and elevated differentiation of follicular cells [39]. At day 14 during the first postnatal 
catagen phase, we observed distinct Ddit4 staining patterns between WT and VDR-/- hair follicles 
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and epidermis derived from littermates (Figure 4B). Both types of mice showed Ddit4 expression in 
the inner root sheath (IRS) of the hair follicle and moderate levels within the interfollicular 
epidermal regions (Figure 4B). However, there was slightly higher, atypical Ddit4 expression in 
VDR-/- follicles. These punctate regions of increased Ddit4 expression within VDR-/- follicles were 
observed in nearly every follicle within superbasal sections at day 14 (Figure 4BIII–VI). Given the 
stress inducible role of Ddit4, we classified these areas as stress compartments (SC) within 
VDR-deficient follicles. These results suggest that VDR-deficient hair follicles that are transitioning 
between catagen-telogen exhibit increased cellular stress. 
 
Figure 4. Ddit4α-positive stress compartments present in VDR-/- morphogenic hair follicles (column 
2). (A) Chart depicting the morphogenic and post-morphogenic stages of the hair cycle up to 
post-natal day 49 (P49); (B) At day 14, hair follicles are within the first postnatal morphogenic early 
catagen (regression) phase. In WT (I,II) and VDR-/- (IV,V)animals, Ddit4 is expressed throughout the 
inner root sheath (IRS), but not in the bulb of the hair follicle (HF). In both genotypes, Ddit4 was 
expressed within the interfollicular (IF) epidermis. Hair follicles of VDR-/- animals exhibit 
Ddit4-positive stress compartments (SC, white arrows) (IV). In the right panel (III,VI), a lower 
magnification (20×) is presented where each hair follicle is outlined with a white dotted line. Ddit4 
immunostaining is counter-detected with Alexa® 594 and nuclei stained with DAPI; (C) At day 29, 
hair follicles are within the second postnatal anagen (growth) phase. In WT skin, Ddit4 expression 
was attenuated within the IF and hair follicle compared to day 14. Asterisks reflect the zoom of the 
respective hair follicle. In VDR-/- hair follicles, there was aberrant and increased Ddit4 expression 
throughout the length of the follicle (bulb to inner root sheath) compared to WT. There was a similar 
expression pattern in the utricles (u) and the INF; (D) At day 48, WT skin display telogen hair 
follicles with quiescent morphology. Ddit4 expression was enhanced and uniform throughout the 
epidermis (ep), dermis (dm) and follicular epithelium. In contrast, VDR-/- skin exhibited significant 
reduction of Ddit4 throughout the skin. C (corneocytes). For immunostaining, representative slides 
are presented. Dotted white lines outline individual hair follicles or the epidermal-dermal junction; 
(E) Hair follicle bulge stem cells from 29-day-old animals were fluorescence-activated cell sorting 
(FACS) purified and analyzed with RT-qPCR. There was no significant change in Ddit4 message 
level between WT and VDR-/- bulge stem cells (n = 4 experiments per genotype). 
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By day 29, initiation of post-morphogenic anagen in the hair follicle is characterized by 
increased cell proliferation in the follicular epithelium below the activated bulge. During anagen in 
WT skin, Ddit4 expression was substantially reduced within the hair follicle and interfollicular 
regions compared to day 14 (Figure 4C), suggesting a reduction of its growth-inhibitory functions. 
Despite this reduction, there was more residual Ddit4 within the interfollicular epidermis compared 
to the follicle. At this stage, VDR-null hair follicles are degenerated and exhibit an abnormal 
morphology depicted by follicular dystrophy, IRS hyperplasia and massive dilation of the junctional 
canal consistent with previous work [17]. In contrast to normal hair follicles, VDR-null follicles 
exhibit increased and variegated expression of Ddit4 throughout the dystrophic follicular 
epithelium and interfollicular regions. There was a statistically significant increase in normalized 
average fluorescent intensity (VDR-/-: 538 ± 31 a.u.; WT: 74 ± 11 a.u., n = 8 follicles, p < 0.01) within the 
bulb region of VDR-/- hair follicles when compared to WT samples at this stage. We also found that 
the utricules (u), i.e., the epidermal portion of abnormal hair follicles, also expressed Ddit4 in the 
lining epithelium. By day 48, the hair follicles of normal animals remain in the resting telogen phase 
and are kept dormant for another five weeks. The epidermis at this stage also expresses major factors 
of differentiation [4]. In WT animals, the epidermis and follicular epithelium uniformly expressed 
increased levels of Ddit4 (Figure 4D), presumably to help maintain a growth-inhibiting, dormant 
state. Furthermore, dermal fibroblasts in WT skin also expressed Ddit4. On the other hand, 
VDR-null mice at day 48 exhibit epidermal hyperplasia and increased epidermal corneocytes (c), 
suggesting abnormal shedding of cornified material. Remarkably, Ddit4 expression was 
non-existent within VDR-null skin at telogen. Ddit4 expression was suppressed throughout the 
epidermis, remaining non-exogenic follicular epithelium and within the dermis as well. 
Furthermore, there was increased dermal cellularity in VDR-/- skin, inversely correlating with the 
level of Ddit4 (Figure 4D). 
2.5. The VDR Does Not Regulate Ddit4 within Bulge Keratinocyte Stem Cells 
Besides epidermal and follicular keratinocytes, the cutaneous niche consists of many different 
cell types, including bulge keratinocyte stem cells (KSCs). It was recently shown that hair follicle 
growth and stem cell exhaustion in mice are linked to mTOR dysregulation as a means to maintain 
genetic integrity of the stem cell population [40,41]. We therefore hypothesized that the unliganded 
VDR maintains proper Ddit4 levels, and hence mTOR function, within KSCs. We compared Ddit4 
transcript levels under unliganded conditions within 29-day-old KSCs, a period in which KSCs are 
activated (Figure 4C). We isolated living bulge KSC populations from anagen hair follicles of WT 
and VDR-/- littermates using FACs purification according to the established markers α6hi and CD34+ 
[42]. Based on these preparations, we observed no difference in Ddit4 message levels between WT 
and VDR-/- KSCs. These results suggest no relationship between the VDR and mTOR signaling 
towards possible stem cell exhaustion and no effect on the hair loss phenotype, raising the question 
of primary defects in progenitor cells instead. 
2.6. Impaired Ddit4/Ddit4 and Krt10/Krt10 Expression in the Neo-Epidermis of Wounds from VDR-/- Mice 
The cause for delayed onset of cutaneous wound closure in global VDR-null mice is unclear. 
Based on this, we studied the association between Ddit4 and VDR during the cutaneous wound 
repair process. Miced aged 47 days mice were subjected to 3.5 mm trunk punch biopsies and tissues 
were harvested and processed for RT-qPCR, BrdU (5-bromo-2′-deoxyuridine) labeling, and 
immunocytochemistry six days after injury. First, we monitored and compared Ddit4 and Krt10 
(keratin 10) message levels between WT and VDR-/- animals. Krt10 is an early marker of 
differentiating daughter cells inthe stratum basale which faces toward the epidermal surface. We 
confirmed the lower Ddit4 message levels within uninjured VDR-/- epidermis, which was 
accompanied by a significant reduction in Krt10 mRNA compared to uninjured WT tissue (Figure 
5A). Relative to uninjured skin, there was a significant decrease in both Ddit4 and Krt10 message 
levels in WT wounds six days post-injury, representing the early-intermediate phase of the 
re-epithelialization process. Compared to WT wounds six days after injury, Ddit4 and Krt10 mRNA 
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levels were further attenuated in VDR-/- wounds. Histological analysis of wound closure showed 
larger wound openings (Figure 5B, red lines) in VDR-/- mice after six days. Interestingly, within 
VDR-/- injured skin, in vivo BrdU labeling revealed an increased number of proliferating epidermal 
and follicular keratinocytes compared to WT samples at the wound edges, marking a potential 
reserve of cells impaired in the re-epithelialization process (Figure 5BII,IV; representative black box). 
In both genotypes, BrdU also labeled damaged hair follicles. Particular to VDR-/- tissue were 
BrdU-positive proliferating dermal fibroblasts (red arrows). Next we monitored Ddit4 and Krt10 
expression with immunohistochemistry in the newly restored epidermis six days after injury. We 
observed moderate expression of Ddit4 within the newly re-epithelized wound edge in WT animals 
(Figure 5BV,VI; representative red box). In contrast, there was a comparable decrease in 
Ddit4-positive cells present within the neo-epidermis in VDR-/- animals (Figure 5B, VII and VIII; 
representative red box). In WT neo-epidermis, there were diffuse cells with high Krt10 
immuno-reactivity in contrast to VDR-/- wounds (Figure 5C). Overall, these findings suggest that the 
loss of Ddit4/Krt10-positive cells in wounded VDR-/- animals contributes to the impaired 
re-epithelialization process. 
 
Figure 5. Reduction of Ddit4 in the re-epithelized wounds of VDR-/- animals (column 1.5). (A) 
RT-qPCR analysis of the wound repair process from excised wounds. For uninjured samples, 
comparisons were made between genotypes. Six days following injury, sample comparisons were 
made between the respective uninjured genotypes. One-way ANOVA at an α = 0.05 (95% confidence 
interval) and Tukey’s multiple comparison post-tests were utilized. Significance is denoted with 
asterisks: * p < 0.05, ** p < 0.01 (n = 4 samples per genotype and time point); (B) Representative slides 
showing 5-bromo-2′-deoxyuridine (BrdU) immunohistochemical (I–IV) and Ddit4 
immunofluorescence (V–VIII) staining of WT and VDR-/- skins six days following injury. Wound 
closure is depicted by the horizontal red bars. Black boxed areas in the 4× slides represent the 
BrdU-labeled magnified regions (II and IV)). Red-boxed areas represent the Ddit4-labeled magnified 
regions (V–VII). In the BrdU slides, black arrows depict proliferating epidermal and follicular 
keratinocytes. Red arrows depict proliferating dermal fibroblasts. In the Ddit4 panels, the dotted 
white line marks the re-epithelialized area. Nuclei are marked in blue with 
4′,6-diamidino-2-phenylindole (DAPI), while Ddit4 is labeled in red. ES: eschar; GR: granulation 
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tissue; EP: epidermis; DM dermis; (C) Krt10 immunostaining within the neo-epidermis (demarcated 
by dashed lines) six days following injury. 
2.7. Ddit4-Deficient Mouse Embryonic Fibroblasts Are Resistant to the Pro-Differentiation Actions of Vitamin 
D 
Although the initial data suggests a functional association between VDR and Ddit4, the impact 
of Ddit4 on vitamin D function is unclear. As Ddit4 is expressed in dermal fibroblasts and 
dysregulated in VDR-/- skin (Figure 4D), mouse embryonic fibroblasts (MEFs) derived from Ddit4-/- 
and WT animals (kindly provided by LeifW. Ellisen) were tested for any differences in classic 
vitamin D anti-proliferative responses. We observed more spindle-shaped cells, characteristic of 
mitotic cells, in Ddit4-deficient MEFs even following 50 nM 1,25D3 treatment (Figure 6A, right 
panels). Measurement of cell proliferation in WT MEFs showed that even at the lowest concentration 
range of 1,25D3, cell proliferation was inhibited compared to the baseline (dotted line) (Figure 6B). At 
50nM 1,25D3, there was an approximate 10% decrease in cell proliferation in WT samples, but no 
effect in Ddit4-/- MEFs. It was only at the highest level (100 nM) of 1,25D3 that Ddit4-/- MEFs exhibited 
comparable effects on cell number to WT cells (Figure 6A,B), possibly succumbing to apoptosis [43]. 
Next, we performed BrdU-incorporation studies using MEFs treated with 50–75 nM 1,25D3 (Figure 
6C,D), and observed statistically significant decreases in BrdU incorporation within WT, but not 
Ddit4-/- MEFs. The fibroblast maturation marker vimentin was also decreased in Ddit4-/- MEFs when 
compared to WT samples (Figure 6EI). Lastly, to gain insight into signaling events, we performed 
quantitative real-time PCR analysis to monitor Vdr expression and induction of Cyp24a1 (Figure 
6EII–IV). Interestingly, Ddit4-/- MEFs expressed more Vdr compared to normal MEFs (Figure 6EII). 
As a result, there was a concomitant increase in induction of Cyp24a1 in Ddit4-/- MEFs (Figure 
6EIII,IV). These results suggest that despite the increase in Vdr and its signaling capacity in MEFs 
lacking Ddit4, vitamin D is unable to differentiate these cells due to specific defects in the DDIT4 
signaling cascade. In conclusion, Ddit4-deficient MEFs were resistant to low-to-moderate vitamin D 
treatments, and Ddit4 is a downstream effector of liganded VDR actions to promote cellular 
differentiation within fibroblasts. 
 
Figure 6. Ddit4-/- mouse embryonic fibroblasts are resistant to the pro-differentiation actions of 
vitamin D (1 column). (A) Representative images of WT and Ddit4-/- mouse embryonic fibroblasts 
(MEFs). MEFs were untreated or treated with a serial dilution of 1,25D3 (0.39–100 nM) for 24 h; (B) 
Cell counts performed after 1,25D3 treatment to calculate the proliferation % relative to the untreated 
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sample. One-way ANOVA at an α = 0.05 (95% confidence interval) and Tukey’s multiple comparison 
post-tests were utilized. Significance is denoted with asterisks: * p < 0.05, ** p < 0.01 (n = 3 experiments 
per conditions and genotype); (C) Representative BrdU-labeled MEFs shown after 1,25D3 treatment 
for 12 h. DAPI-positive cells were marked using the Imaris (Bitplane) software to perform 
quantitative analysis. Bar = 50 µm; (D) Quantification of BrdU-labeled MEFs after 1,25D3 treatment. 
Significance is denoted with asterisks: ** p < 0.01, *** p < 0.001 (n = 3 experiments per conditions and 
genotype); (E) Quantitative PCR analysis of Vimentin in Wt and KO MEFs after 6 hours with or 
without vitamin D, * p < 0.05 (I). Quantitative PCR analysis of  MEFs treated or untreated with low 
or high concentrations of 1,25D3 for 6 h (II–IV). Increased expression of Vdr (II) and induction of 
Cyp24a1 (III,IV) within Ddit4-/- MEFs. (n = 3 preparations of each cell line). 
3. Discussion 
3.1. Insights into Ddit4-VDR 
Perturbation of VDR expression in humans and mice is associated with alopecia. The results 
reported here therefore provide novel insights into biological and clinical applications of vitamin D 
and skin function. Our data show that the mTOR inhibitor, Ddit4, is a direct transcriptional target of 
VDR in epidermal keratinocytes. Regulation of mTOR activity is a major component of “checks and 
balances” of energy homeostasis within a cell. Ddit4, a mitochondria-resident protein, represses 
mTOR signaling by activating TSC2 (tuberin), a guanosine triphosphate (GTP) hydrolyzing enzyme 
(GTPase) activating protein (GAP), which then stimulates the small GTPase Ras homolog enriched 
in brain (Rheb) in its GDP-bound form to inactivate mTOR [25]. Dysregulation of mTOR signaling 
can lead to a plethora of diseases including cancer and metabolic disorders. Studies have shown that 
1,25D3 or its analogues can suppress tumor cell growth by upregulation of Ddit4 in various cancer 
cell model systems [44]. Suppression of mTOR via Ddit4 activation results in attenuation in both cell 
size and growth rate, comparable to that observed after nutrient and growth factor deprivation [45]. 
Conversely, Ddit4 levels are mitigated under growth-like conditions [27]. The importance of Ddit4 
in regulating cytoprotection and survival is highlighted in the Ddit4-/- mouse line that is associated 
with enhanced mTOR activity [25]. DDIT4-/- mice are known to be resistant to a diverse set of stress 
conditions such as those caused by oxidative stress in the retina, tobacco smoke-induced 
emphysema, steroid-induced atrophy in the skin and apoptosis of lung epithelial cells caused by 
ceramide [46–48]. Mouse Ddit4 resides in a genomic region on chromosome 10 (10: 
59316668-74913026), which forms the only syntenic cluster on human chromosome 10 (10: 
53435340-73103214), emphasizing its conservation and functional importance. In addition, previous 
studies found that simultaneous loss of Drosophila scylla and charybdis, which are homologs of the 
human DDIT4 and DDIT4-like genes, generated flies that showed mild overgrowth [49]. In contrast, 
enhanced expression of Ddit4 can promote apoptotic cell death or terminal differentiation in certain 
cell types [50], including VDR-deficient follicular epithelial cells observed in our studies. 
3.2. Hair Follicle Defects in VDR-Deficient Animals 
Our data support the notion that abnormalities in Ddit4 signaling disrupt follicular energy 
homeostasis to affect follicular integrity in VDR-/- animals. It was previously reported that the 
inability of VDR-deficient animals to initiate a new post-morphogenic hair cycle was due to primary 
defects within KSCs [13]. Findings from the same group observed no change in differentiation 
markers of VDR-deficient neonatal keratinocytes in culture, concluding that the mutant follicular 
keratinocytes during the morphogenic period are normal [5]. In contrast, the findings of this study 
and others have shown that there exist defects within the follicular epithelium of VDR-/- mice during 
the catagen-to-telogen morphogenic period [17]. In this regard, it has been shown that the failure of 
the follicular epidermis to maintain the hair follicle in VDR-deficient animals likely represents the 
compromised adhesion and motility capacity of surface cells along the follicle at the onset of anagen, 
and not due to functional defects within label-retaining KSCs [14,19]. These defects can further 
compromise lineage progression and differentiation status of follicular keratinocytes lacking a 
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functional VDR. Furthermore, we observed no differences in Ddit4 expression within VDR-/- KSCs, 
suggesting that Ddit4-related defects reside either in the hair germ or more in differentiated 
progenitor cells. It is well known that mTOR activation propagates metastasis and matrix-stimulated 
cell migration, and treatment with mTOR inhibitors such as rapamycin can block cell motility under 
numerous experimental conditions (reviewed in [51]). There are also several examples how primary 
defects of the strictly regulated morphogenic catagen-telogen transition can lead to failed initiation 
of the ensuing anagen hair cycle, much like that observed in VDR-/- animals [52,53]. Overall, our 
findings may have uncovered a critical cog—mTOR signaling—in the full understanding of how 
hair follicles become impaired and degenerate in VDR-/- animals. 
To date, it is unclear if the stress compartments identified in VDR-/- morphogenic follicles are 
formed due to systemic and/or local stress stimuli. As a number of sensing cues impinge on the 
Ddit4-mTOR signaling pathway, it will require additional efforts to identify the specific cues within 
the VDR-/- follicles. It is commonly known that damaged hair follicles endure premature catagen 
initiation to inhibit proper hair follicle growth [54], further supporting our findings and suggesting 
precocious and prolonged catagen-to-telogen transition in VDR-deficient follicles. This speculation 
is supported by a recent study which performed RT-qPCR analysis on plucked VDR-/- hair follicles 
during morphogenetic days 13 and 15 [17]. In the study, at day 13 there was a significant increase in 
pro-apoptotic CASP3 (caspase 3) transcripts in VDR-/- follicles compared to controls, and at day 15 
there was a reported decrease in Shh (sonic hedgehog) message levels. Epithelial Shh is a major 
driver of hair follicle morphogenesis, and its decrease in VDR-/- follicles hints at perturbations in the 
process. Furthermore, it is unclear if the elevated Ddit4 level in VDR-/- follicles is a harbinger of 
apoptosis activation [17], as there is a clear link between persistent Ddit4 activation with 
programmed cell death [55]. Lastly, we are unclear whether the Ddit4-positive stress compartments 
are associated with clearance of dysfunctional cellular debris, as DDIT4 upregulation and mTOR 
suppression are positively correlated with autophagocytosis [56]. Overall, we speculate that 
follicular degeneration in VDR-null animals does not reflect defects in the VDR-Ddit4 axis within 
KSCs, rather in the cells that make up the cycling portion of the hair follicle (Figure 7). 
 
Figure 7. Early stress in VDR-/- hair follicles and epidermal regulation of Ddit4 by the VDR (column 
1.5). Schema depicting the major findings. (A) VDR-/- hair follicles (HFs) exhibit DDIT4+ stress 
compartments, marked in red, during morphogenesis which prolongs the telogen phase; (B) The 
VDR regulates Ddit4 expression during epidermal homeostasis and wound healing responses. By 
day 48, VDR-/- hair follicles have degenerated resulting in loss of Ddit4expression; (C) Proposed 
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functional role of Ddit4 and mTOR during epidermal maturation and hair growth. During epidermal 
maturation, VDR signaling induces Ddit4 expression to block mTOR cascades. During the initiation 
of anagen, Ddit4 levels are suppressed in order to stimulate the mTOR growth-promoting cascade; 
(D) Proposed involvement of DDIT4 in regulating the pro-differentiation effects of vitamin D in 
embryonic fibroblasts. 
3.3. Epidermal Wounding Defects 
The defect in VDR-/- hair follicles highlights the dichotomy which exists in the epidermis (Figure 
7). Our data suggests that within uninjured epidermal keratinocytes, both in vitro and in vivo, the 
VDR regulates Ddit4 message levels in a concentration and age-dependent manner, respectively. By 
day 48 the epidermis normally expresses high levels of differentiation markers, yet animals void of 
VDR associate with reduced epidermal differentiation [17,57]. This is consistent with reduced levels 
of Ddit4 within skin of VDR-/- mice. This finding is also consistent with increased Shh in the 
epidermis of VDR-/- mice [57], which can induce a basal-like phenotype as well as basal cell 
carcinomas in the skin. Thus, we speculate that the VDR maintains epidermal homeostasis via direct 
transcriptional control of Ddit4 over time. 
Skin wounding triggers an acute inflammatory response with the innate immune system 
contributing both to protection against invasive organisms and invasion of inflammatory cells into 
the wounded area. These cells release a variety of cytokines and growth factors that stimulate the 
proliferation and migration of dermal and epidermal cells to close the wound. Mice globally lacking 
the VDR or the enzyme CYP27B1 exhibit decreased lipid content of the lamellar bodies leading to a 
defective permeability barrier [58], and a defective response of the innate immune system to 
invading infections acting through dermal TGF-β signaling [2]. We observed delayed wound closure 
in the VDR-/- mice, which is consistent with most reports [3,14,59]. This is in contrast to one study 
that showed no difference in wound closure of VDR-/- animals [2], which may reflect differences in 
the age of the animals and/or severity and conditions of the wounds. Regardless, studies 
investigating “epithelial-specific” ablation of the VDR resulted in delayed wound closure attributed 
to impaired β-catenin signaling within epidermal stem cells [3]. Recently, epithelial-specific ablation 
of phosphatase and tensin homolog Pten and tuberous sclerosis 1 Tsc1 (inhibitors of mTOR) has 
shown that mTOR activation can dramatically increase epithelial cell migration and cutaneous 
wound closure [40]. Although we observed the opposite phenomena, one could argue for global 
VDR ablation having systemic effects on the immune system that impedes the subsequent steps of 
the healing process, such as re-epithelialization. 
Fibroblasts also migrate into the wounded area and proliferate to deposit a provisional 
extracellular matrix consisting of reforming granulation tissue. Keratinocytes migrate across the 
injured dermis above the provisional matrix and begin to proliferate. By 3–10 days after injury, the 
wound is filled with granulation tissue, and fibroblasts are recruited to the wound by growth factors 
from macrophages. Fibroblasts then trans-differentiate into myofibroblasts, leading to wound 
contraction and immature collagen deposition assisting in wound closure. At this stage, the apical 
wound portion is overlaid with a neo-epidermis associated with fibroblasts. At six days after 
wounding we observed sporadic Ddit4-postive cells within the re-epithelized wound within the 
neo-epidermis in WT animals. The identity of these cells is unclear, and may signify the transitioning 
(myo)fibroblasts during the healing process or keratinocytes. At this stage the levels of both Ddit4/ 
Ddit4 and Krt10/Krt10 decreased relative to uninjured tissue representing the development-like 
regenerative steps of healing. In contrast, VDR-/- neo-epidermis did not harbor any Ddit4-positive 
cells, suggesting loss of or delayed formation and recruitment of this specialized subset of 
regenerative cells during the healing process. Importantly, we observed primary ligand resistance to 
VDR signaling within Ddit4-/- MEFs, suggesting potential dermal fibroblastic regulation and defects 
in VDR-/- animals as well. 
4. Material and Methods 
4.1. Animal Maintenance 
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VDR-/- animals (B6.129S4-Vdrtm1Mbd/J, company, city, country) with targeted ablation of the 
second zinc finger were purchased from the Jackson Laboratory (JAX: 006133, Bar Harbor, ME, 
USA). Animal studies were approved by the institutional animal care and use committee (First 
Affiliated Hospital of Chongqing Medical University; SYXK2012-0001, June 2015). Animals were 
kept in a clean (virus- and parasite-free) facility under a 12-h light, 12-h dark cycle on a diet enriched 
with calcium (2%), phosphorus (1.25%) and lactose (20%) to prevent hyperparathyroidism, rickets 
and osteomalacia, but not alopecia [16]. 
4.2. Mouse Puncture Assay 
Male 48-day-old littermate mice (n = 4 mice per time point) were anesthetized and received a 3.5 
mm biopsy skin punch on each side of the trunk. Six days after puncture, reepithelialization was 
monitored by harvesting tissue in 10% buffered formalin. Paraffin embedded wounds were 
processed for immunohistochemistry. For reverse transcription quantitative PCR (RT-qPCR) 
analysis, wounds (n = 4 per genotype and time point) were excised, trimmed and then processed 
using the RNeasy Plus Universal Mini Kit (Qiagen, Gaithersburg, MD, USA). 
4.3. Chromatin Immunoprecipitation (ChIP) 
We performed the ChIP assays using ChIP-IT® Express Chromatin Immunoprecipitation Kits 
from Active Motif. Primary keratinocytes were treated for 15 minutes with 10nM 1,25D3 (Biomol, 
Plymouth Meeting, PA, USA) reconstituted in absolute ethanol. Chromatin was cross-linked with 
1% formaldehyde, quenched with glycine and processed in 1% sodium dodecyl sulfate (SDS) cell 
lysis buffer. Samples were enzyme-treated to yield fragmented chromatin. Chromatin samples were 
incubated with 10µg ChIP-grade anti-RNA polymerase II (ab26721; Abcam, Boston, MA, USA) and 
anti-VDR (sc-1008x; Santa Cruz Biotechnology, Santa Cruz, CA, USA) antibodies. Quantitative PCR 
(qPCR) was performed with primers flanking putative vitamin D response element (VDRE) 
consensus sequences in the regulatory region of mouse Ddit4 (based on the GRCm38 mouse 
assembly; available on: https://www.ncbi.nlm.nih.gov/genome/52). Primers were designed using 
Primer3 (bioinfo.ut.ee/primer3-0.4.0/primer3). Ddit4 target: Ddit4-1: (forward) 5-ttcccatccttttgcagttc-3, 
(reverse) 5-ccactgcccaatttcatctt-3; Ddit4-2: (forward) 5-tcagggtcccagtgtcctac-3, (reverse) 
5-caattcaatggaacccagga-3; and Ddit4-3: (forward) 5-ggtacctttctcccctgctc-3, (reverse) 5-ctctcccctcgccttagc-3. 
Control primers: OC (osteocalcin): (forward) 5-caggggcagacactgaaaa-3, (reverse) 
5-aggagactgccaggttctga-3; VDR-S1 (VDRE site): (forward) 5-gtagccatccatgtggcttt-3, (reverse) 
5-ccagacggaagcctagagaa-3; and non-specific control (calponin) based on [60]. The non-specific 
control was used to normalize for DNA content and to calculate the relative enrichment of the 
regulatory regions according to the formula of Livak and Schmittgen [61] and presented as fold 
enrichment. Samples were run on a 1.5% tris-acetic acid- ethylenediaminetetraacetic acid (TAE) 
agarose gel for visualization. 
4.4. In Vivo/In Vitro 5-bromo-2′-deoxyuridine (BrdU) Labeling and Immunocytochemistry 
For cell proliferation studies, wounded animals were injected intraperitoneally with 
5-bromo-2′-deoxyuridine (BrdU) at 0.25 mg/gram (Roche) three hours prior to the time that the 
animals were sacrificed. Wounds were excised, fixed, and processed for immunocytochemical 
analysis. Proliferating cells were detected using a BrdU labeling and detection kit (Roche, 
Indianapolis, IN, USA) according to the manufacturer′s instructions. For in vitro studies, sterile 
filtered 10 µM BrdU was prepared in media. After 12 h of vitamin D treatment, cells were washed 
with phosphate buffered saline (PBS), and replaced with the BrdU solution for a 2 h labeling period. 
Cells were fixed and then detected as above. Cell counting analysis was performed using the “spot” 
function on the Imaris (version 8.4, Bitplane, Concord, MA, USA) software. 
4.5. Fluorescence-Activated Cell Sorting of Hair Follicle Stem Cells 
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Skin from 29-day-old wildtype (WT) and VDR-/- littermates was used to harvest hair follicle 
stem cells. The purification of bulge stem cells from mice was performed using established 
expression markers α6hi/ Cluster of differentiation 34 (CD34+) [12]. The antibodies used were: 
Anti-Integrin α6 phycoerythrin (PE) conjugated, ab95703 (Abcam); anti-CD34, ab8158 (Abcam); and 
Alexa Fluor® 488 (Thermofisher, Waltham, MA, USA) secondary antibody at ~1 µg antibody per 106 
cells. The double-labeled cell suspensions were placed in FACS tubes on ice for sorting on a BD 
FACSCalibur™ (BD Biosciences, San Jose, CA, USA). BD Falcon tubes containing 50% chelex-treated 
FBS in PBS were used to collect double-labeled KSCs. Using four sets (n = 4 experiments per 
genotype) of four 29-day-old postnatal mice, we enriched KSCs for RT-qPCR analysis. KSCs were 
further collected in the appropriate RNA stabilization reagent supplied in the RNeasy mini kit 
(Qiagen). 
4.6. Immunofluorescent and Immunohistochemical Labeling of Skin 
Skin tissues were obtained from the lower dorsal region. Wounds were excised and fixed in 
10% formalin/PBS, processed and embedded vertically in paraffin. Tissues sections were mounted 
on microscope slides and processed for immunofluorescence staining with detergent (0.1% triton X). 
DDIT4 labeling was detected using an DDIT4 antibody (Abcam, ab106356) at 1:200 dilution 
followed by secondary staining with Alexa Fluor® 594 (Thermofisher). Slides were mounted in 
Vectashield® mounting medium with DAPI (Vector Laboratory). Immunohistochemistry was 
performed using anti-K10 (Abcam, ab9026) at 1:100 dilution with HRP-conjugated secondary 
antibody and DAB. Slides were imaged using a FV1000 (Olympus, Center Valley, PA, USA) 
confocal microscope. Control slides were included by negating primary antibodies or substituting 
with pre-immune sera (data not shown). For confocal imaging, a series of three-dimensional “z-axis” 
image projections of follicular axial depths were obtained in XYZ scan mode set to 1 µm/slice and a 
sample speed of 12.5 µs/pixel. All other parameters (e.g., pinhole diameter, gain, laser intensities) 
were kept constant during imaging. The fluorescence intensity was never saturated (max. 4096 
intensity level) during imaging. The series of projected “z-axis” images were used to calculate 
average fluorescent intensity profiles per 594 nm channel using the freehand analysis tool in the 
Fluoview software v. 4.1 (Olympus). The proximal bulb region of Ddit4-stained hair follicles were 
averaged per image, as well as follicles of negative controls averaged per image to generate average 
background fluorescence intensities. Ddit4 levels in the bulb were relatively compared and 
background corrected between for eight individual follicles per genotype. 
4.7. Ddit4-/- Mouse Embryonic Fibroblasts (MEFs) and Cell Count Measurement 
Ddit4-/- and wild type MEFs were generously provided by Leif W. Ellisen as previously 
described [25], and maintained in Dulbecco’s Modified Eagle’s medium (DMEM)/10% fetal bovine 
serumPen/Strep. Cells were maintained at 37 °C in a 95% air/5% CO2 atmosphere. Cells were plated 
in 24-well tissue culture plates at 2 × 104 cells per cm2 and then replaced with fresh media and 1,25D3. 
Cells were trypsinized and counted 24 h later using an automated cell counter (Countess II FL, 
Thermofisher). Three sample preparations were made per condition in order to calculate the % of 
cells remaining (n = 3). 
4.8. mRNA Reverse Transcription Quantitative PCR (RT-qPCR) Analysis 
Total RNA was purified using the RNeasy mini kit (Qiagen). cDNA was synthesized from 
300ng total RNA by SuperScript Reverse Transcriptase III (Invitrogen, Carlsbad, CA, USA) using 
random hexamers. RT-qPCR analysis was performed with a Stratagene MX-3005P instrument 
utilizing TaqMan system reagents from ABI, and target genes were normalized to ATCB (β-actin) 
expression. TaqMan® assays used: (1) Control ATCB, β-actin (VIC®-labeled), assay ID 4352341E; (2) 
1,25-dihydroxyvitamin D3 24-hydroxylase (Cyp24a1, FAM™-labeled), assay ID 4331182; (3) Ddit4 
(FAM™-labeled), assay ID 4331182; and (4) Krt10 (FAM™-labeled), assay ID 4331182. All reactions 
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were performed in triplicate experimental conditions. Data are presented as comparable arbitrary 
expression units. 
4.9. Primary Neonatal Keratinocytes and mVDR Transient Transfection 
Primary keratinocytes were harvested from neonatal pups aged 2–3 days using a trypsin 
floating method. Briefly, the pups were skinned and then floated on 0.05% trypsin (Sigma, St. Louis, 
MO, USA) at low temperature for 12 h. The epidermal sheets were harvested, minced, and then 
agitated with a stir bar in a keratinocyte growth medium on ice for 1 h. The medium consisted of: 
calcium and magnesium-free Eagle’s Minimal Essential Medium (Gibco, Carlsbad, CA, USA), FBS 
with reduced calcium, 2 ng/mL human recombinant epidermal growth factor (EGF) (Novoprotein, 
Summit, NJ, USA) supplemented with 1x penicillin–streptomycin (Gibco). Calcium in the serum was 
removed by treating FBS with a chelating resin, Chelex®100 (Bio-Rad Laboratories, Hercules, CA, 
USA). Calcium concentration was adjusted to 0.05 mM by adding calcium chloride solution. The cell 
suspension was then filtered using a 40 micron mesh and were seeded (4 × 104 cells/cm2) in tissue 
culture plates pre-coated with type I collagen (Gibco, R-011-K). Cultures were incubated in 8% CO2 
and 92% humidified atmosphere at 34 °C, and medium was changed every 2–3 days. The untagged 
mouse vitamin D receptor expression vector (pCMV6) was purchased from Origene (BC006716). 
Transfection of primary keratinocytes was conducted using the BioT reagent (Biolands) and 
protocol. 
5. Conclusions 
In conclusion, we show that Ddit4 marks early stress compartments within VDR-/- hair follicles 
which intiate during the morphogenic period. Importantly, we implicate Ddit4 as a functional 
component of growing anagen follicles during the hair cycle. Ddit4 is also a direct transcriptional 
target of the VDR within epidermal keratinocytes, highlighting its ligand-dependent genomic role 
during vitamin D signaling. VDR regulates Ddit4 during epidermal homeostasis and the wound 
repair process, namely the proper differentiation and stratification of the neo-epidermis post injury. 
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